Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
South Florida Medical Research
mi
from
Aventura, FL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Advanced Clinical Research
mi
from
West Jordon, UT
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Advanced Clinical Research
mi
from
West Jordon, UT
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Clinical Research Associates of Tidewater
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Samved Hospital
mi
from
Ahmedabad,
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Samved Hospital
mi
from
Ahmedabad,
Click here to add this to my saved trials
Early or Late Foley Removal After Thoracotomy
Optimal Timing of Foley Catheter Removal in Patients Undergoing Thoracic Surgery With Epidural Analgesia: A Randomized, Controlled Trial
Status: Enrolling
Updated:  1/12/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Early or Late Foley Removal After Thoracotomy
Optimal Timing of Foley Catheter Removal in Patients Undergoing Thoracic Surgery With Epidural Analgesia: A Randomized, Controlled Trial
Status: Enrolling
Updated: 1/12/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
Status: Enrolling
Updated:  1/13/2016
Hall Health Primary Care Center, University of Washington
mi
from
Seattle, WA
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
Status: Enrolling
Updated: 1/13/2016
Hall Health Primary Care Center, University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  1/15/2016
Study Center
mi
from
Chandler, AZ
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 1/15/2016
Study Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Status: Enrolling
Updated:  1/28/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Status: Enrolling
Updated: 1/28/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Detroit, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
St. Louis, MO
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Indiana, PA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Indiana, PA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Research Site
mi
from
Rosario,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Research Site
mi
from
Rosario,
Click here to add this to my saved trials
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Newport Beach, CA
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated:  2/8/2016
mi
from
Leuven,
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated: 2/8/2016
mi
from
Leuven,
Click here to add this to my saved trials
Laparoscopic Pyeloplasty Registry and Database
Laparoscopic Pyeloplasty: A Registry and Database
Status: Enrolling
Updated:  2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Laparoscopic Pyeloplasty Registry and Database
Laparoscopic Pyeloplasty: A Registry and Database
Status: Enrolling
Updated: 2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  2/23/2016
Study Center
mi
from
Chandler, AZ
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 2/23/2016
Study Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  2/23/2016
Study Center
mi
from
Chandler, AZ
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 2/23/2016
Study Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Sylmar, CA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Lima, OH
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Lima, OH
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Research Site
mi
from
Cordoba,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Research Site
mi
from
Cordoba,
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
University of Southern California
mi
from
Los Angeles, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
Harbor UCLA Medical Center
mi
from
Torrance, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
University of California, San Diego
mi
from
San Diego, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Prospective Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Status: Enrolling
Updated:  3/15/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Prospective Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Status: Enrolling
Updated: 3/15/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Nitrofurantoin and Urinary Tract Infections (UTIs)
A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse
Status: Enrolling
Updated:  3/18/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Nitrofurantoin and Urinary Tract Infections (UTIs)
A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse
Status: Enrolling
Updated: 3/18/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
A Randomized Comparison of Concomitant Incontinence Procedures Performed With Abdominal Sacral Colpopexy: the Burch Versus Mid-urethral Sling Trial
Status: Enrolling
Updated:  3/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
A Randomized Comparison of Concomitant Incontinence Procedures Performed With Abdominal Sacral Colpopexy: the Burch Versus Mid-urethral Sling Trial
Status: Enrolling
Updated: 3/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Conservative Treatment of Postprostatectomy Incontinence
Conservative Treatment of Postprostatectomy Incontinence
Status: Enrolling
Updated:  3/21/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Conservative Treatment of Postprostatectomy Incontinence
Conservative Treatment of Postprostatectomy Incontinence
Status: Enrolling
Updated: 3/21/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lidocaine Analgesia for Urethral Catheterization in Children
Randomized Clinical Trial of Lidocaine Analgesia for Urethral Catheterization in Children
Status: Enrolling
Updated:  3/28/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Lidocaine Analgesia for Urethral Catheterization in Children
Randomized Clinical Trial of Lidocaine Analgesia for Urethral Catheterization in Children
Status: Enrolling
Updated: 3/28/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated:  3/28/2016
Skyline Urology
mi
from
Sherman Oaks, CA
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated: 3/28/2016
Skyline Urology
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated:  3/28/2016
Skyline Urology
mi
from
Torrance, CA
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated: 3/28/2016
Skyline Urology
mi
from
Torrance, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Overland Park, KA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
mi
from
Wetumpka, AL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
mi
from
Wetumpka, AL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Surprise, AZ
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Surprise, AZ
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Encinitas, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Oceanside, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Orange, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
mi
from
Templeton, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
mi
from
Templeton, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Celebration, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Celebration, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Orlando, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Berwyn, IL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Berwyn, IL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Evanston, IL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
St. Louis, MO
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Rochester, NY
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
mi
from
Akron, OH
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials